!
!
Sign in / Join ICS
Home
When is treatment clinically relevant compared to placebo for studies in Nocturia?
Holm-Larsen T
1
, van Der Meulen E
2
, Nørgaard J P
2
, Kold Olesen T
2
Abstract Category
Nocturia
Abstract 343
Nocturia
Scientific Podium Poster Session 21
Wednesday 22nd October 2014
17:35 - 17:40
Room B2
Clinical Trial
Hormone Therapy
Nocturia
Quality of Life (QoL)
Voiding Dysfunction
1.
Pharma Evidence,
2.
Ferring Pharmaceuticals
Presenter
T
Tove Holm-Larsen
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
19/05/2024 15:10:32